查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598523

移植市場：依產品、應用和最終用途 – 2025-2030 年全球預測

Transplantation Market by Product (Immunosuppressive Drugs, Tissue Products), Application (Organ Transplantation, Tissue Transplantation), End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年移植市值為286.7億美元，預計2024年將達到310.9億美元，複合年成長率為8.53%，預計到2030年將達到508.6億美元。

移植是一種醫療程序，將器官或組織從一個身體移植到另一個身體，或從供體部位移植到患者體內的另一個位置，以替換受損或功能障礙的器官，目的是恢復。移植的需要主要源自於慢性疾病、急性損傷或導致器官衰竭的先天性缺陷。研究應用包括腎臟、肝臟、心臟、肺臟和胰臟移植，主要最終使用領域為醫院、移植中心和研究機構。市場促進因素包括慢性病盛行率上升、移植技術的進步以及醫療基礎設施意識和投資的增加。再生醫學以及透過組織工程和 3D 列印開發生物人工器官正在湧現商機，並且有望透過緩解捐贈者短缺來改變遊戲規則。

主要市場統計
基準年[2023] 286.7億美元
預測年份 [2024] 310.9億美元
預測年份 [2030] 508.6億美元
複合年成長率（%） 8.53%

然而，市場成長受到諸如嚴格的監管要求、高成本以及圍繞器官捐贈和分配的道德問題等挑戰的限制。此外，免疫排斥和長期併發症仍然是主要的臨床挑戰。為了利用潛在的商機，相關人員應關注免疫抑制治療的創新，並制定提高捐贈者意識的策略。當生技公司和醫療保健提供者合作研究異種移植和幹細胞療法時，可能會有顯著的成長前景。此外，器官保存和運輸技術等領域為減少移植延誤和提高器官活力提供了有希望的途徑。隨著市場的發展，公司應優先考慮患者教育和支持計劃，以提高移植成功率和接受者的生活品質，從而在競爭格局中佔據有利地位。由於技術的快速進步和醫療保健政策的變化，市場動態變得越來越活躍，需要不斷創新和適應才能保持競爭力。

市場動態：揭示快速發展的移植市場的關鍵市場洞察

供需的動態交互作用正在改變移植市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病盛行率增加
    • 器官捐贈與登記意識不斷增強
    • 組織庫增加
  • 市場限制因素
    • 缺乏治療器官衰竭的器官捐贈
  • 市場機會
    • 移植手術技術不斷進步
    • 各國政府和非政府組織加強積極努力
  • 市場挑戰
    • 與移植相關的倫理和文化問題日益增多

波特五力：駕馭移植市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解移植市場的外部影響

外部宏觀環境因素在塑造移植市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解移植市場的競爭狀況

對移植市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣置入市場廠商績效評估

FPNV定位矩陣是評估移植市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製移植市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，移植市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病增加
      • 器官捐贈與登記意識不斷增強
      • 組織庫建置進展
    • 抑制因素
      • 缺乏治療器官衰竭的器官捐贈
    • 機會
      • 移植手術的技術進步
      • 各國政府和非政府組織加強積極努力
    • 任務
      • 與移植相關的倫理和文化問題日益增多
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章移植市場：依產品

  • 免疫抑制藥物
  • 紙巾產品

第7章移植市場：依應用分類

  • 器官移植
  • 組織移植

第8章移植市場：依最終用途分類

  • 醫院
  • 移植中心

第9章美洲移植市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太移植市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲移植市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Arthrex, Inc.
  • Australian Red Cross Lifeblood
  • BioLife Solutions Inc.
  • Dr. Franz Kohler Chemie GmbH
  • LifeCell International Pvt. Ltd.
  • Mid-America Transplant
  • Novartis AG
  • Sanofi SA
  • Stryker Corporation
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd
  • TransMedics, Inc.
  • Veloxis Pharmaceuticals
  • Zimmer Biomet
Product Code: MRR-031685195793

The Transplantation Market was valued at USD 28.67 billion in 2023, expected to reach USD 31.09 billion in 2024, and is projected to grow at a CAGR of 8.53%, to USD 50.86 billion by 2030.

Transplantation refers to the medical procedure wherein an organ or tissue is transferred from one body to another or from a donor site to another location in the patient's body, aimed at replacing damaged or failing organs to restore functionality. The necessity for transplantation arises primarily from chronic diseases, acute injuries, or congenital defects resulting in organ failure. Applications include kidney, liver, heart, lung, and pancreas transplants, with major end-use areas being hospitals, transplant centers, and research institutes. Significant market drivers include the rising prevalence of chronic diseases, advancements in transplantation technology, and increasing awareness and investments in healthcare infrastructure. Opportunities are emerging from regenerative medicine and the development of bioartificial organs through tissue engineering and 3D printing, which are poised to transform the landscape by alleviating donor organ shortages.

KEY MARKET STATISTICS
Base Year [2023] USD 28.67 billion
Estimated Year [2024] USD 31.09 billion
Forecast Year [2030] USD 50.86 billion
CAGR (%) 8.53%

However, market growth is constrained by challenges, such as stringent regulatory requirements, high costs, and ethical concerns around organ donation and allocation. Furthermore, immunological rejection and long-term complications remain significant clinical challenges. To capitalize on potential opportunities, stakeholders should focus on innovation in immunosuppressive therapies and develop strategies to increase donor awareness. Collaboration between biotechnology firms and healthcare providers for research in xenotransplantation and stem cell therapy could unlock significant growth prospects. Moreover, areas like organ preservation and transport technologies offer promising avenues for reducing transplant delays and enhancing organ viability. As the market evolves, companies should prioritize patient education and support programs to improve transplant success rates and quality of life for recipients, thus positioning themselves advantageously within the competitive landscape. The nature of the transplantation market is increasingly dynamic, shaped by fast-paced technological advancements and shifting healthcare policies, necessitating continuous innovation and adaptation to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transplantation Market

The Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases
    • Growing awareness about organ donation and registration
    • Rising development of tissue banks
  • Market Restraints
    • Shortage of organ donation for treatment of organ failure
  • Market Opportunities
    • Rising technological advancement in transplant surgeries
    • Growing active initiatives by government and non-government organizations
  • Market Challenges
    • Growing ethical and cultural issues associated with transplantations

Porter's Five Forces: A Strategic Tool for Navigating the Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transplantation Market

A detailed market share analysis in the Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transplantation Market

A strategic analysis of the Transplantation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transplantation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Arthrex, Inc., Australian Red Cross Lifeblood, BioLife Solutions Inc., Dr. Franz Kohler Chemie GmbH, LifeCell International Pvt. Ltd., Mid-America Transplant, Novartis AG, Sanofi S.A., Stryker Corporation, Terumo Corporation, Teva Pharmaceutical Industries Ltd, TransMedics, Inc., Veloxis Pharmaceuticals, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Immunosuppressive Drugs and Tissue Products.
  • Based on Application, market is studied across Organ Transplantation and Tissue Transplantation.
  • Based on End Use, market is studied across Hospitals and Transplant Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases
      • 5.1.1.2. Growing awareness about organ donation and registration
      • 5.1.1.3. Rising development of tissue banks
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of organ donation for treatment of organ failure
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising technological advancement in transplant surgeries
      • 5.1.3.2. Growing active initiatives by government and non-government organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Growing ethical and cultural issues associated with transplantations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transplantation Market, by Product

  • 6.1. Introduction
  • 6.2. Immunosuppressive Drugs
  • 6.3. Tissue Products

7. Transplantation Market, by Application

  • 7.1. Introduction
  • 7.2. Organ Transplantation
  • 7.3. Tissue Transplantation

8. Transplantation Market, by End Use

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Transplant Centers

9. Americas Transplantation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Transplantation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Transplantation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Arthrex, Inc.
  • 3. Australian Red Cross Lifeblood
  • 4. BioLife Solutions Inc.
  • 5. Dr. Franz Kohler Chemie GmbH
  • 6. LifeCell International Pvt. Ltd.
  • 7. Mid-America Transplant
  • 8. Novartis AG
  • 9. Sanofi S.A.
  • 10. Stryker Corporation
  • 11. Terumo Corporation
  • 12. Teva Pharmaceutical Industries Ltd
  • 13. TransMedics, Inc.
  • 14. Veloxis Pharmaceuticals
  • 15. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSPLANTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSPLANTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 143. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023